logo-loader
viewGilead Sciences, Inc.

Gilead Sciences' remdesivir shows improvement in coronavirus patients with moderate pneumonia

Patients taking a 5-day course of treatment recover faster compared to the standard of care

Gilead Sciences, Inc. - Gilead Sciences' remdesivir shows improvement in coronavirus patients with moderate pneumonia

Gilead Sciences Inc (NASDAQ:GILD) said its investigational drug remdesivir helps coronavirus patients with moderate pneumonia to recover faster compared to the standard of care.

A late-stage trial evaluated patients in 5-day and 10-day courses, but the latter did not show statistical significance.

READ: Gilead Sciences, Roche to study remdesivir/Actemra combination in coronavirus patients

Remdesivir is currently approved as emergency treatment for coronavirus in several countries after three trials confirmed it allows for a faster recovery.

It is also being evaluated in combination with Roche’s arthritis treatment Actemra for severe coronavirus cases.

Neil Wilson at Markets.com said the news was not particularly well received by the market as “it’s a long way from a slam dunk Covid-beater”.

Shares fell by over 3% after the announcement, trimming losses to 1% dip to US$74.50 in premarket trading.

Quick facts: Gilead Sciences, Inc.

Price: 76.32 USD

NASDAQ:GILD
Market: NASDAQ
Market Cap: $95.73 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Inspired Energy raises up to £35mln in placing and open offer and fully...

Inspired Energy PLC's (LON:INSE) Mark Dickinson speaks to Proactive after announcing they've raised £35mln and struck a deal to acquire the 60% of Ignite Energy that it does not already own. Dickinson says the acquisition will accelerate the group's organic growth in optimisation services. In an...

1 day, 8 hours ago

2 min read